U.S. Markets open in 8 hrs 53 mins

Onconova Therapeutics, Inc. (ONTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.04-0.15 (-2.89%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.76
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 328.95
52 Week Low 32.85
50-Day Moving Average 36.14
200-Day Moving Average 311.11

Share Statistics

Avg Vol (3 month) 31.23M
Avg Vol (10 day) 3191.88k
Shares Outstanding 5236.61M
Implied Shares Outstanding 6N/A
Float 221.88M
% Held by Insiders 10.55%
% Held by Institutions 115.08%
Shares Short (Apr 14, 2021) 46.02M
Short Ratio (Apr 14, 2021) 40.43
Short % of Float (Apr 14, 2021) 42.55%
Short % of Shares Outstanding (Apr 14, 2021) 42.54%
Shares Short (prior month Mar 14, 2021) 411.62M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep 25, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3May 20, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-10,819.48%

Management Effectiveness

Return on Assets (ttm)-71.56%
Return on Equity (ttm)-283.48%

Income Statement

Revenue (ttm)231k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)90.00%
Gross Profit (ttm)231k
EBITDA -24.98M
Net Income Avi to Common (ttm)-25.16M
Diluted EPS (ttm)-0.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.02M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.97
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-23.07M
Levered Free Cash Flow (ttm)-13.54M